MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Eye treatment company Avedro lands $25 million | Funding Roundup

Eye treatment company Avedro lands $25 million | Funding Roundup

By

Funding

Avedro Inc. landed $25 million in a series C financing round, company officials announced yesterday.

The Waltham, Mass.-based company will use the funds to expand its commercial operations overseas.

Avedro, a private company, also plans to pursue U.S. Food and Drug Administration clearance for its Vedera cornea flattening treatment, designed to treat near-sightedness, and its KXL corneal cross-linking system.

The KXL system won CE Mark approval in the European Union in November 2010.

Check out the MassDevice podcast with Avedro Inc. CEO David Muller from December 2010.

Funding was led by SCP Vitalife and followed by Aperture Venture Partners who joined by existing investors Prism VentureWorks, De Novo Ventures, Flagship Ventures, Borealis Ventures and Echelon Ventures, according to the release.

As part of the round Jeff Dykan of SCP Vitalife will join Avedro’s board of directors, and Eric Sillman of Aperture Venture Partners comes on as a board observer.

Here’s a roundup of other dealflow and investment news:

  • Cardiovascular Systems announced $3.5 million loan agreement
    Cardiovascular Systems Inc. (NSDQ:CSII) announced that it issued a senior convertible promissory to the tune of $3.5 million to Partners for Growth III in exchange for a loan of the same amount pursuant to an agreement made between the companies in April 2010.
    Read more


  • Optical biopsy company closes $2.5 million funding round
    Precision Biopsy, a Boston-based cancer diagnostics company, announced the official close of a $2.5 million round. The funds will go toward product development and preparation market introduction.
    Read more

  • SpineVision touts $5 million
    SpineVision announced that it raised $5 million, which will go primarily toward acceleration market penetration of the Paris-based company’s minimally invasive motion-preservation spinal therapies.

    "We now have a focused and streamlined international operation that is steadfastly penetrating the market," said Gérard Hascoët, chairman & CEO of SpineVision.
    Read more

  • CareFusion lands $550 million credit facility
    CareFusion Corp. (NYSE:CFN) arranged a $550 million unsecured revolving credit facility with JPMorgan Chase Bank this week. The credit has a five-year term and allows the San Diego-based company to request up to $200 million more under certain conditions.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Henry Schein investors push back on executive pay
    Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May… […]
  • Creo Medical inks collaboration agreement with Intuitive
    Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday… […]
  • MedTrace Pharma moves forward on 15 O-water imaging tech
    MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate… […]
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]

Leave a Reply